Yitzhak Shamir Medical Center
Welcome,         Profile    Billing    Logout  
 6 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rachmiel, Marianna
SURMOUNT-ADOLESCENTS-2, NCT06439277: A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities

Recruiting
3
300
Europe, Canada, US, RoW
Tirzepatide, LY3298176, Placebo
Eli Lilly and Company
Obesity, Weight Gain
05/27
06/27
NCT06672939: A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

Recruiting
3
125
Europe, Japan, US, RoW
Orforglipron, LY3502970, Placebo
Eli Lilly and Company
Obesity, Overweight
02/27
03/27
SURPASS-PEDS, NCT05260021 / 2021-003612-31: A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

Active, not recruiting
3
99
Europe, US, RoW
Tirzepatide Dose 1, Tirzepatide Dose 2, Placebo
Eli Lilly and Company, Eli Lilly and Company
Type2 Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, T2D, T2DM (Type 2 Diabetes Mellitus), Glucose Metabolism Disorders, Endocrine System Diseases, Metabolic Disease
07/24
02/25
ADVANCE, NCT06672549: A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Not yet recruiting
3
125
Europe, Japan, US, RoW
Orforglipron, LY3502970, Placebo
Eli Lilly and Company
Obesity, Overweight
02/27
03/27
NCT06075667: A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Recruiting
3
150
Europe, Canada, US, RoW
Tirzepatide, LY3298176, Placebo
Eli Lilly and Company
Obesity, Overweight
10/26
10/26
NCT02923323: Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in Healthy

Active, not recruiting
N/A
32
RoW
MRI including DTI , EEG, CGMS, Neurocognitive tests
Assaf-Harofeh Medical Center, Bar-Ilan University, Israel, Hadassah Medical Organization
Diabetes Mellitus, Type 1
10/19
05/25
NCT02397200: Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls

Recruiting
N/A
160
RoW
Nutritional supplementation standardized formula, Placebo
Rabin Medical Center
Growth Problem, Low Weight
08/24
08/24
NCT04412200: Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes Mellitus

Recruiting
N/A
36
RoW
Hyperbaric oxygen chamber (HBOC)
Assaf-Harofeh Medical Center
T1DM
11/24
05/26
NCT02973061: The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents

Recruiting
N/A
100
RoW
Questionnaires
Assaf-Harofeh Medical Center
Growth Hormone Deficiency, Attention Deficit Disorder, Idiopathic Short Stature
12/24
12/24
Heller, Lior
No trials found
Moravski, Gil
No trials found

Download Options